Huiqin Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Huiqin Xu has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Chuanchuan He
Department of Central Laboratory, Jiaxing Maternity and Child Health Care Hospital, Affiliated Women and Children Hospital, Jiaxing University, Jiaxing, People’s Republic of China
1 shared publication Liu Xu
Affiliated Hospital of Jiaxing University, Jiaxing, China
1 shared publicationRuixue Ma
Department of Pharmaceutics, College of Medicine, Jiaxing University, Zhejiang, China
1 shared publicationSirui Hang
Zhejiang Chinese Medical University, Zhejiang, China
1 shared publication- Xiaojuan Zhang
Jiaxing Key Laboratory for Photonanomedicine and Experimental Therapeutics, Department of Pharmaceutics, College of Medicine, Jiaxing University, Jiaxing 314001, China
1 shared publication
Latest Publications
- Open Access
- 6 August 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-11
Recent advances in calcium peroxide nanomedicines for breast cancer treatment
As a typical solid tumor, breast cancer is characterized by a tumor microenvironment featuring hypoxia, acidosis, and highly reductive conditions. These factors contribute to treatment resistance (e.g., chemoresistance) through various mechanisms, thereby diminishing therapeutic efficacy. Calcium peroxide (CaO2) can generate multiple bioactive molecules (metal ions, H2O2, O2, and OH−) in acidic or neutral environment, making it a promising biomaterial for cancer therapy. Recently, breast cancer has been extensively targeted using CaO2 nanoparticles in both cellular and murine models. In this review, we first provide a summary of strategies employing CaO2 nanomedicine-based breast cancer therapies, then discuss the obstacles and development directions of CaO2 application in breast cancer therapy.
- 6 August 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-11
Open AccessRecent advances in calcium peroxide nanomedicines for breast cancer treatment
As a typical solid tumor, breast cancer is characterized by a tumor microenvironment featuring hypoxia, acidosis, and highly reductive conditions. These factors contribute to treatment resistance (e.g., chemoresistance) through various mechanisms, thereby diminishing therapeutic efficacy. Calcium peroxide (CaO2) can generate multiple bioactive molecules (metal ions, H2O2, O2, and OH−) in acidic or neutral environment, making it a promising biomaterial for cancer therapy. Recently, breast cancer has been extensively targeted using CaO2 nanoparticles in both cellular and murine models. In this review, we first provide a summary of strategies employing CaO2 nanomedicine-based breast cancer therapies, then discuss the obstacles and development directions of CaO2 application in breast cancer therapy.